ADJUVANT 5 FU-IRRADIATION-5 FU FOLLOWING MASTECTOMY IN HIGH-RISK PATIENTS

被引：0
|
作者：
RAMIREZ, G
机构：
[1] UNIV WISCONSIN,DIV CLIN ONCOL,MADISON,WI 53706
[2] UNIV WISCONSIN,DIV RADIOTHERAPY,MADISON,WI 53706
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1976年 / 17卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [21] Seizures following subconjunctival 5-FU therapy
    René Hoehn
    Julia Lamparter
    Norbert Pfeiffer
    Urs Vossmerbaeumer
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, 249 : 145 - 146
  • [22] Adjuvant chemotherapy of patients with primary breast cancer (PABC) by fluorouracil (5-FU)
    Hazova, TV
    Koritova, LI
    Ilyin, NV
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S32 - S32
  • [23] ORAL 5-FLUOROURACIL (5-FU) AS AN ADJUVANT TO SURGERY IN CARCINOMA OF COLON
    HARVEY, H
    BADDER, E
    DEMUTH, W
    NAHRWOLD, D
    PATTERSON, L
    RICCI, J
    SHAVER, W
    WHITE, D
    LIPTON, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 314 - 314
  • [24] SR-90 VS 5-FU AS ADJUNCT TO SURGERY FOR PATIENTS AT HIGH-RISK OF TRABECULECTOMY FAILURE - A PROSPECTIVE RANDOMIZED TRIAL
    ODONOGHUE, EP
    SAUNDERS, DC
    AYLIFFE, W
    RIDGWAY, AEA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1432 - 1432
  • [25] CARDIOTOXICITY OF 5-FU DURING ADJUVANT CHEMOTHERAPY IN CANCER OF COLON
    BUGNON, PY
    ELHAGE, A
    BOUNOUA, F
    GAUTIERBENOIT, C
    BULLETIN DU CANCER, 1992, 79 (04) : 365 - 367
  • [26] PSYCHIATRIC MORBIDITY FOLLOWING MASTECTOMY - THE IDENTIFICATION OF PATIENTS AT HIGH-RISK
    WHITFORD, P
    MCARDLE, JMC
    MCARDLE, CS
    BRITISH JOURNAL OF SURGERY, 1986, 73 (06) : 504 - 504
  • [27] 5-Fluorouracil (5-FU) plus leucovorin versus 5-FU leucovorin plus interferon-A given as adjuvant chemotherapy in colon cancer
    Papacostas, P
    Stathopoulos, GP
    Malamos, NA
    Michailakis, E
    Rigatos, S
    Golematis, B
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 752 - 752
  • [28] Factors affecting the risk of lymphedema following mastectomy with adjuvant irradiation
    Hinrichs, CS
    Watroba, NL
    Rezaishiraz, H
    Fassl, K
    Muir, R
    Giese, WL
    Hurd, TC
    Kraybill, WG
    Edge, SB
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S55 - S56
  • [29] LARGE-SCALE TRIAL FOR ADJUVANT TREATMENT IN HIGH-RISK RESECTED COLORECTAL CANCERS - RATIONALE TO TEST THE COMBINATION OF LOCO-REGIONAL AND SYSTEMIC CHEMOTHERAPY AND TO COMPARE L-LEUCOVORIN PLUS 5-FU TO LEVAMISOLE PLUS 5-FU
    ROUGIER, P
    NORDLINGER, B
    ANNALS OF ONCOLOGY, 1993, 4 : S21 - S28
  • [30] 5-fluorouracil (5-FU) plasma exposure and outcome in patients receiving a TPF (taxotere, cisplatin, 5-FU) chemotherapy
    Legand, C.
    Blasco, H.
    Benz, I.
    Chapet, C.
    Le Guellec, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2009, 23 : 25 - 25
12345